BRIEF-Genmab: FDA grants priority review for daratumumab By: Reuters: Company News October 10, 2016 at 01:08 AM EDT * U.S. FDA grants priority review for daratumumab in relapsed multiple myeloma Read More >> Related Stocks: Gen Digital Inc